BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 29897453)

  • 21. Regulation of the novel adipokines/ hepatokines fetuin A and fetuin B in gestational diabetes mellitus.
    Kralisch S; Hoffmann A; Lössner U; Kratzsch J; Blüher M; Stumvoll M; Fasshauer M; Ebert T
    Metabolism; 2017 Mar; 68():88-94. PubMed ID: 28183456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.
    Hanley AJ; Williams K; Festa A; Wagenknecht LE; D'Agostino RB; Kempf J; Zinman B; Haffner SM;
    Diabetes; 2004 Oct; 53(10):2623-32. PubMed ID: 15448093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First trimester prediction of gestational diabetes mellitus using plasma biomarkers: a case-control study.
    Correa PJ; Venegas P; Palmeiro Y; Albers D; Rice G; Roa J; Cortez J; Monckeberg M; Schepeler M; Osorio E; Illanes SE
    J Perinat Med; 2019 Feb; 47(2):161-168. PubMed ID: 30205647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-hour post-load plasma glucose levels are associated with elevated liver enzymes.
    Succurro E; Arturi F; Grembiale A; Iorio F; Fiorentino TV; Andreozzi F; Sciacqua A; Hribal ML; Perticone F; Sesti G
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):713-8. PubMed ID: 21764272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver enzymes and incident diabetes in China: a prospective analysis of 10 764 participants in the Guangzhou Biobank Cohort Study.
    Xu L; Jiang CQ; Schooling CM; Zhang WS; Cheng KK; Lam TH
    J Epidemiol Community Health; 2015 Nov; 69(11):1040-4. PubMed ID: 26139641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus.
    Zhang Y; Lu X; Hong J; Chao M; Gu W; Wang W; Ning G
    Endocrine; 2010 Oct; 38(2):181-7. PubMed ID: 20972737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prior lactation reduces future diabetic risk through sustained postweaning effects on insulin sensitivity.
    Bajaj H; Ye C; Hanley AJ; Connelly PW; Sermer M; Zinman B; Retnakaran R
    Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E215-E223. PubMed ID: 27965206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women.
    Buchanan TA; Xiang A; Kjos SL; Lee WP; Trigo E; Nader I; Bergner EA; Palmer JP; Peters RK
    Diabetes; 1998 Aug; 47(8):1302-10. PubMed ID: 9703332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of the intravenous and oral glucose tolerance tests for detecting subtle impairments in insulin sensitivity and beta-cell function in former gestational diabetes.
    Tura A; Mari A; Prikoszovich T; Pacini G; Kautzky-Willer A
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):237-43. PubMed ID: 18194489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postpartum microalbuminuria after gestational diabetes: the impact of current glucose tolerance status.
    Kew S; Swaminathan B; Hanley AJ; Connelly PW; Sermer M; Zinman B; Retnakaran R
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1130-6. PubMed ID: 25559401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deteriorating beta cell function is the dominant determinant of progression from normal glucose tolerance to prediabetes/diabetes in young women following pregnancy.
    Retnakaran R; Ye C; Kramer CK; Hanley AJ; Connelly PW; Sermer M; Zinman B
    Diabetologia; 2023 Nov; 66(11):2154-2163. PubMed ID: 37612415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rising plasminogen activator inhibitor-1 and hypoadiponectinemia characterize the cardiometabolic biomarker profile of women with recent gestational diabetes.
    Mehmood S; Ye C; Connelly PW; Hanley AJ; Zinman B; Retnakaran R
    Cardiovasc Diabetol; 2018 Oct; 17(1):133. PubMed ID: 30301460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Circulating Determinants of Beta-Cell Function in Women With and Without Gestational Diabetes.
    Retnakaran R; Ye C; Kramer CK; Connelly PW; Hanley AJ; Sermer M; Zinman B
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2683-91. PubMed ID: 27023450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic insulin resistance is an early determinant of declining β-cell function in the first year postpartum after glucose intolerance in pregnancy.
    Retnakaran R; Qi Y; Ye C; Hanley AJ; Connelly PW; Sermer M; Zinman B
    Diabetes Care; 2011 Nov; 34(11):2431-4. PubMed ID: 21926287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-gravid physical activity and reduced risk of glucose intolerance in pregnancy: the role of insulin sensitivity.
    Retnakaran R; Qi Y; Sermer M; Connelly PW; Zinman B; Hanley AJ
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):615-22. PubMed ID: 18793347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of physical activity and fitness with hepatic steatosis, liver enzymes, and insulin resistance in children with overweight/obesity.
    Medrano M; Arenaza L; Migueles JH; Rodríguez-Vigil B; Ruiz JR; Labayen I
    Pediatr Diabetes; 2020 Jun; 21(4):565-574. PubMed ID: 32237015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids.
    Thamer C; Tschritter O; Haap M; Shirkavand F; Machann J; Fritsche A; Schick F; Häring H; Stumvoll M
    Horm Metab Res; 2005 Apr; 37(4):246-51. PubMed ID: 15952086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
    Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease.
    Sheng X; Che H; Ji Q; Yang F; Lv J; Wang Y; Xian H; Wang L
    Horm Metab Res; 2018 May; 50(5):397-402. PubMed ID: 29723898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher level of GGT during mid-pregnancy is associated with increased risk of gestational diabetes mellitus.
    Kong M; Liu C; Guo Y; Gao Q; Zhong C; Zhou X; Chen R; Xiong G; Yang X; Hao L; Yang N
    Clin Endocrinol (Oxf); 2018 May; 88(5):700-705. PubMed ID: 29385633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.